Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takahiro Yamauchi

Showing results (1-10 of 239) with videos related to

Pageof 24
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2016
Treatment of acute myeloid leukemia under relapsed/refractory conditions or in older adultsTakahiro Yamauchi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2018
[Incorporation of novel agents into the treatment for acute myeloid leukemia]Takahiro Yamauchi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 6, 2018
[Acute myeloid leukemia of the elderly: recent progresses in therapy]Takahiro Yamauchi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 5, 2021
[Overview]Takahiro Yamauchi
International Journal of Clinical Oncology|May 20, 2019
Novel therapeutic strategy based on genetic and epigenetic abnormalities for myeloid neoplasmsTakahiro Yamauchi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 17, 2022
[Ⅲ. Bcl-2 Inhibitor in AML Therapy]Naoko Hosono, Takahiro Yamauchi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 21, 2018
[I. Recent Progress in Therapies for Acute Myeloid Leukemia]Takahiro Yamauchi, Naoko Hosono
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 16, 2008
[Primary hyperuricemia due to decreased renal uric acid excretion]Takahiro Yamauchi, Takanori Ueda
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2011
[Nilotinib as a second-line treatment for chronic myeloid leukemia]Takahiro Yamauchi, Takanori Ueda
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 27, 2024
[Antibody-Drug Conjugate for Treating Leukemia and Lymphoma-The Present Status, Problems, and Future Development]Naoko Ida, Takahiro Yamauchi
Pageof 24

Showing results (1-10 of 239) with videos related to

Sort By:
Pageof 24
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2016
Treatment of acute myeloid leukemia under relapsed/refractory conditions or in older adultsTakahiro Yamauchi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2018
[Incorporation of novel agents into the treatment for acute myeloid leukemia]Takahiro Yamauchi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 6, 2018
[Acute myeloid leukemia of the elderly: recent progresses in therapy]Takahiro Yamauchi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 5, 2021
[Overview]Takahiro Yamauchi
International Journal of Clinical Oncology|May 20, 2019
Novel therapeutic strategy based on genetic and epigenetic abnormalities for myeloid neoplasmsTakahiro Yamauchi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 17, 2022
[Ⅲ. Bcl-2 Inhibitor in AML Therapy]Naoko Hosono, Takahiro Yamauchi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 21, 2018
[I. Recent Progress in Therapies for Acute Myeloid Leukemia]Takahiro Yamauchi, Naoko Hosono
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 16, 2008
[Primary hyperuricemia due to decreased renal uric acid excretion]Takahiro Yamauchi, Takanori Ueda
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2011
[Nilotinib as a second-line treatment for chronic myeloid leukemia]Takahiro Yamauchi, Takanori Ueda
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 27, 2024
[Antibody-Drug Conjugate for Treating Leukemia and Lymphoma-The Present Status, Problems, and Future Development]Naoko Ida, Takahiro Yamauchi
Pageof 24